The use of bacterial phage associated lytic enzymes to prevent food poisoning

Details for Australian Patent Application No. 2001297870 (hide)

Owner New Horizons Diagnostics Corporation

Inventors Trudil, David; Fischetti, Vincent; Loomis, Lawrence

Agent Davies Collison Cave

Pub. Number AU-A-2001297870

PCT Number PCT/US01/42886

PCT Pub. Number WO2002/102405

Priority 09/704,148 02.11.00 US

Filing date 1 November 2001

Wipo publication date 2 January 2003

International Classifications

A61K 038/43 Medicinal preparations containing peptides - Enzymes

C12S 003/00 Treatment of animal or plant materials or micro-organisms

C12N 009/36 Enzymes, e.g. ligases (6.) - acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme

A23L 003/3463 Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs - Organic compounds

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 09/704,148 02.11.00 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2001297870

14 June 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001297871-NOVEL BICYCLIC ISOXAZOLINONES AS ANTIBACTERIAL AGENTS

2001297869-METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE BY CO-ADMINISTERING A CHEMOKINE WITH AN ANTIGEN